We are live on ! Find out more
SCM

Stonebridge Capital Management Portfolio holdings

AUM $220M
This Fund
S&P 500
This Quarter Est. Return
+3.53%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$254M
AUM Growth
-$20.2M
Cap. Flow
-$28.1M
Cap. Flow %
-11.07%
Top 10 Hldgs %
38.34%
Holding
155
New
6
Increased
10
Reduced
81
Closed
12

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$1.11M
2
DVA icon
DaVita
DVA
+$579K
3
ALC icon
Alcon
ALC
+$234K
4
UPS icon
United Parcel Service
UPS
+$207K
5
FITB
Fifth Third Bancorp
FITB
+$207K

Top Sells

Rank Stock Value
1
SBUX icon
Starbucks
SBUX
+$1.51M
2
GILD icon
Gilead Sciences
GILD
+$1.47M
3
DIS icon
Walt Disney
DIS
+$1.21M
4
NVS icon
Novartis
NVS
+$998K
5
MSFT icon
Microsoft
MSFT
+$982K

Sector Composition

Rank Sector Weight
1 Technology 26.55%
2 Healthcare 17.46%
3 Industrials 11.58%
4 Consumer Staples 9.42%
5 Energy 9.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RIG icon
126
Transocean
RIG
$5.62B
$103K 0.04%
16,074
+4,870
+43% +$36.2K
SCOR icon
127
Comscore
SCOR
$112M
$95K 0.04%
+922
New +$197K
TRT
128
Trio-Tech International
TRT
$99.8M
$95K 0.04%
66,148
– –
TMQ
129
Trilogy Metals
TMQ
$549M
$49K 0.02%
16,500
-4,300
-21% -$11.4K
SBBP
130
DELISTED
Strongbridge Biopharma plc.
SBBP
$41K 0.02%
12,950
+2,000
+18% +$7.34K
MVIS icon
131
Microvision
MVIS
$85.7M
$31K 0.01%
38,950
+1,250
+3% +$1.11K
SN
132
DELISTED
Sanchez Energy Corporation
SN
$31K 0.01%
305,600
+116,025
+61% +$11.8K
EVRC
133
DELISTED
EVERCEL INC
EVRC
$24K 0.01%
10,000
– –
NAK
134
Northern Dynasty Minerals
NAK
$779M
$7K ﹤0.01%
+12,225
New +$6.35K
AND
135
DELISTED
ANDREA ELECTRONICS CORP
AND
$1K ﹤0.01%
18,000
– –
BAC icon
136
Bank of America
BAC
$433B
– –
-8,019
Closed -$222K
BIIB icon
137
Biogen
BIIB
$30.7B
– –
-2,682
Closed -$634K
CVS icon
138
CVS Health
CVS
$134B
– –
-6,369
Closed -$343K
DXJ icon
139
WisdomTree Japan Hedged Equity Fund
DXJ
$7.13B
– –
-6,500
Closed -$329K
INDA icon
140
iShares MSCI India ETF
INDA
$6.88B
– –
-11,750
Closed -$414K
NRO
141
Neuberger Real Estate Securities Income Fund Inc
NRO
$193M
– –
-10,480
Closed -$50K
ZTS icon
142
Zoetis
ZTS
$31.9B
– –
-2,975
Closed -$299K
CLDR
143
DELISTED
Cloudera, Inc.
CLDR
– –
-15,545
Closed -$170K
VAR
144
DELISTED
Varian Medical Systems, Inc.
VAR
– –
-4,052
Closed -$574K
DRV
145
DELISTED
DEBT RESOLVE INC COM STK
DRV
$0 ﹤0.01%
75,000
-5,000
-6% –
CELG
146
DELISTED
Celgene Corp
CELG
– –
-2,132
Closed -$201K
2 3 4 5
6

Similar funds

TLCM
Twin Lakes Capital Management Redwood Shores, California $220M AUM 31.75% 1-Year Est. Return
RM
Radcliff Management New York $220M AUM 22.57% 1-Year Est. Return
DA
DCM Advisors New York $220M AUM 23.37% 1-Year Est. Return
MDCM
Morgan Dempsey Capital Management Menomonee Falls, Wisconsin $220M AUM 18.32% 1-Year Est. Return
LPP
Long Path Partners Stamford, Connecticut $220M AUM 25.96% 1-Year Est. Return
AWM
Aberdeen Wealth Management Lake Bluff, Illinois $219M AUM 16.64% 1-Year Est. Return
TCG
Transcendent Capital Group Edmond, Oklahoma $219M AUM 19.72% 1-Year Est. Return
FA
Financial Avengers Oakland, California $219M AUM 26.12% 1-Year Est. Return

Stonebridge Capital Management's Q2 2019 Portfolio in Review

As of Q2 2019, Stonebridge Capital Management held 155 positions worth $254M, down 7.4% from $274M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Stonebridge Capital Management withdrew a net $28.1M in Q2 2019, closing 12 positions and reducing 81 holdings. Its most notable exit was Biogen, an estimated $634K position sold in full.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Stonebridge Capital Management opened a new position in Alcon worth $247K.

  • Stonebridge Capital Management's largest Q2 2019 buy was Alcon: 3,988 shares worth $247K.
  • Stonebridge Capital Management added most to Bristol-Myers Squibb in Q2 2019, an estimated $1.11M increase.
  • Stonebridge Capital Management's biggest Q2 2019 reduction was Starbucks, cutting an estimated $1.51M.
  • Stonebridge Capital Management fully exited Biogen in Q2 2019, selling an estimated $634K.
  • Stonebridge Capital Management's ten largest holdings make up 38% of its $254M portfolio in Q2 2019.
  • Stonebridge Capital Management opened 6 new positions and closed 12 in Q2 2019.
  • Stonebridge Capital Management's portfolio value fell 7.4% quarter-over-quarter to $254M.

Based on Stonebridge Capital Management's 13F filing for Q2 2019, filed 12 Jul 2019.